NeoGenomics Inc (NEO)
14.80
-0.19
(-1.27%)
USD |
NASDAQ |
May 17, 16:00
14.79
-0.01
(-0.07%)
After-Hours: 20:00
NeoGenomics Debt to Equity Ratio: 0.5836 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.5836 |
December 31, 2023 | 0.5716 |
September 30, 2023 | 0.5673 |
June 30, 2023 | 0.5613 |
March 31, 2023 | 0.5501 |
December 31, 2022 | 0.5364 |
September 30, 2022 | 0.5278 |
June 30, 2022 | 0.5116 |
March 31, 2022 | 0.496 |
December 31, 2021 | 0.4805 |
September 30, 2021 | 0.4677 |
June 30, 2021 | 0.4629 |
March 31, 2021 | 0.6286 |
December 31, 2020 | 0.2421 |
September 30, 2020 | 0.2498 |
June 30, 2020 | 0.2515 |
March 31, 2020 | 0.1893 |
December 31, 2019 | 0.1908 |
September 30, 2019 | 0.1997 |
June 30, 2019 | 0.2027 |
March 31, 2019 | 0.3053 |
December 31, 2018 | 0.3144 |
September 30, 2018 | 0.3195 |
June 30, 2018 | 0.7751 |
March 31, 2018 | 0.4256 |
Date | Value |
---|---|
December 31, 2017 | 0.4641 |
September 30, 2017 | 0.4798 |
June 30, 2017 | 0.5046 |
March 31, 2017 | 0.5157 |
December 31, 2016 | 0.5139 |
September 30, 2016 | 0.2147 |
June 30, 2016 | 0.2173 |
March 31, 2016 | 0.2203 |
December 31, 2015 | 0.2596 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.0022 |
September 30, 2014 | 0.0883 |
June 30, 2014 | 0.086 |
March 31, 2014 | 0.2162 |
December 31, 2013 | 0.1972 |
September 30, 2013 | 0.1346 |
June 30, 2013 | 0.1642 |
March 31, 2013 | 0.2225 |
December 31, 2012 | 0.9178 |
September 30, 2012 | 0.8713 |
June 30, 2012 | 0.6578 |
March 31, 2012 | 0.7712 |
December 31, 2011 | 0.661 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.1893
Minimum
Mar 2020
0.6286
Maximum
Mar 2021
0.4236
Average
0.4882
Median
Debt to Equity Ratio Benchmarks
Teladoc Health Inc | 0.6726 |
Abbott Laboratories | 0.3758 |
Halozyme Therapeutics Inc | 8.441 |
Verastem Inc | -- |
Ocugen Inc | 0.0935 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 1.640B |
Total Liabilities (Quarterly) | 716.93M |
Shareholders Equity (Quarterly) | 923.41M |
Current Ratio | 7.481 |
Net Debt Paydown Yield | -0.04% |